🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

ENDOMETRIOSIS - MRI

Recruitingn/aAges 18 Years - 50 YearsFemaleUniversity Hospital, Lille
NCT05779462 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Endometriosis is a frequent pathology with an estimated prevalence of 10% of women of childbearing age. There is no exact correspondence between the symptoms described by the patients and the severity of the lesions, which makes clinical diagnosis difficult. It therefore seems important to improve the complementary examinations available to make the diagnosis more precise and to better study the effectiveness of the treatments implemented. The clinical examination and per-surgical findings of patients with deep pelvic endometriosis show a clear decrease in the mobility of the pelvic organs in relation to each other, but few studies have looked at this mobility, which could however have an implication in explaining the pathophysiology of the disease and the symptomatology of the patients, as well as in the detection of lesions preoperatively. The persistence of hypo-mobility could also he

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Patient referred for suspected pelvic endometriosis requiring pelvic MRI * Female, nulliparous, * patient with signed written consent, patient with health insurance, * patient willing to comply with all study procedures and duration Exclusion Criteria: * BMI \> 35, * history of hereditary collagen and elastic tissue disease, * history of pelviperitonitis, * history of major pelvic surgery, * inability to receive informed information, * inability to participate in the entire study, * lack of social security coverage, * refusal to sign consent
💊

What it tests

  • Dynamic MRI Sequence
📍

Where

1 site
Service de chirurgie gynécologique Hôpital Jeanne de Flandre - CHU de LILLE
Lille, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy